NAI Q2 FY2022 net sales down 21.5% YoY to $37.7M; diluted EPS $0.30 vs $0.57

NATURAL ALTERNATIVES INTERNATIONAL INC

2022-Q2 EPS reported $0.81 revenue$76,067,000

Net income $1.8M ($0.30 diluted EPS) vs $3.6M ($0.57) in prior-year quarter; private-label sales fell 25.7% to $33.7M.
Sales to largest customer dropped 48%; CarnoSyn beta-alanine revenue up 46.9% to $4.1M; backlog exceeded $12M due to supply chain issues.
FY2022 guidance: net sales flat to slightly up vs FY2021; H2 net sales expected to increase 10%-13% YoY; operating margin 8%-11%.
Cash and equivalents $19.4M; $20.0M available under credit line; new blending capacity online in Vista, CA.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.